穩健醫療(300888.SZ):2023年全棉時代會員人數增加908萬人 同比增長16%
格隆匯2月1日丨穩健醫療(300888.SZ)披露投資者關係活動記錄表顯示,從2023年的經營結果來看,市場表現更多是消費分層,消費者越來越精細化的趨勢。2023年全棉時代會員人數增加908萬人,同比增長16%;年消費2000元以上的高價值會員總量、會員復購率、會員月均消費頻次都有所提升,可以看出整體會員粘性的提升。另一方面,受到消費謹慎性的影響,消費者囤貨心智減弱,會進行分次購買,客單價隨之受到一些影響。從城市分佈來講,我們看到二線、三線城市的消費增長高於總體,成為引領品牌增長的主陣地。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.